VKH
ZYNE

Virtu KCG Holdings’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Virtu KCG Holdings’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$535K Buy
+31,533
New +$627K 0.01% 1081
2017
Q1 		– Sell
-13,986
Closed -$218K – 3893
2016
Q4 		$218K Sell
13,986
-2,377
-15% -$32K 0.01% 2484
2016
Q3 		$214K Buy
+16,363
New +$155K 0.01% 2305

Other funds holding ZYNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FTIOP
Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return

Virtu KCG Holdings's ZYNE Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2017: 31,533 shares worth $535K. The stake represents 0.01% of the portfolio and ranks #1081 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in ZYNE as recently as Q4 2016.

Virtu KCG Holdings first reported a position in ZYNE in Q3 2016 and has held it in 3 quarters since. 66 funds tracked by Wall St. Rank hold ZYNE as of Q2 2017.

  • Virtu KCG Holdings held 31,533 shares of Zynerba Pharmaceuticals, Inc worth $535K as of Q2 2017.
  • Zynerba Pharmaceuticals, Inc was a new Virtu KCG Holdings position in Q2 2017.
  • Zynerba Pharmaceuticals, Inc made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1081 holding.
  • Virtu KCG Holdings first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2016 and has held it in 3 quarters since.
  • 66 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.